- Home
- INTR vs TMDX Comparison
INTR vs TMDX Comparison
Compare INTR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTR
- TMDX
- Stock Information
- Founded
- INTR 1994
- TMDX 1998
- Country
- INTR Brazil
- TMDX United States
- Employees
- INTR N/A
- TMDX N/A
- Industry
- INTR
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- INTR
- TMDX Health Care
- Exchange
- INTR Nasdaq
- TMDX Nasdaq
- Market Cap
- INTR 2.1B
- TMDX 2.3B
- IPO Year
- INTR N/A
- TMDX 2019
- Fundamental
- Price
- INTR $5.68
- TMDX $70.43
- Analyst Decision
- INTR Buy
- TMDX Buy
- Analyst Count
- INTR 4
- TMDX 10
- Target Price
- INTR $6.48
- TMDX $118.44
- AVG Volume (30 Days)
- INTR 3.8M
- TMDX 1.1M
- Earning Date
- INTR 05-07-2025
- TMDX 04-29-2025
- Dividend Yield
- INTR 1.43%
- TMDX N/A
- EPS Growth
- INTR 176.00
- TMDX N/A
- EPS
- INTR 0.33
- TMDX 1.01
- Revenue
- INTR $743,862,312.00
- TMDX $441,540,000.00
- Revenue This Year
- INTR $81.95
- TMDX $25.24
- Revenue Next Year
- INTR $17.31
- TMDX $19.89
- P/E Ratio
- INTR $16.76
- TMDX $70.14
- Revenue Growth
- INTR 43.28
- TMDX 82.74
- 52 Week Low
- INTR $3.88
- TMDX $55.00
- 52 Week High
- INTR $7.84
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- INTR 53.88
- TMDX 52.31
- Support Level
- INTR $5.52
- TMDX $66.69
- Resistance Level
- INTR $6.08
- TMDX $72.85
- Average True Range (ATR)
- INTR 0.21
- TMDX 3.61
- MACD
- INTR -0.00
- TMDX 0.31
- Stochastic Oscillator
- INTR 56.70
- TMDX 79.31
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.